Achieve Life Sciences (FRA:SP4P) 3-Year EBITDA Growth Rate : 36.70% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Achieve Life Sciences 3-Year EBITDA Growth Rate?

Achieve Life Sciences's EBITDA per Share for the three months ended in Dec. 2023 was €-0.20.

During the past 3 years, the average EBITDA Per Share Growth Rate was 36.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 53.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 57.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Achieve Life Sciences was 72.80% per year. The lowest was -35.50% per year. And the median was 30.50% per year.

Competitive Comparison of Achieve Life Sciences's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Achieve Life Sciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achieve Life Sciences's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's 3-Year EBITDA Growth Rate falls into.

Achieve Life Sciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Achieve Life Sciences (FRA:SP4P) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Achieve Life Sciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Achieve Life Sciences (FRA:SP4P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (FRA:SP4P) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ACHV:USA

Address

22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021

Website

https://www.achievelifesciences.com

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.

Achieve Life Sciences (FRA:SP4P) Headlines

No Headlines